[{"content": "| Dataset | Modality | #Volumes | #Slices | #Masks |\n|---|---|---|---|---|\n| Radiopaedia-MR | MR | 5,414 | 205,039 | \u2013 |\n| Radiopaedia-CT | CT | 8,734 | 812,756 | \u2013 |\n| LiQA [31] | MR | 30 | 2,185 | 1,446 |\n| PanSeg [54] | MR | 766 | 33,360 | 13,779 |\n| PROMISE12 [29] | MR | 50 | 1,377 | 778 |\n| MSD-Prostate [2] | MR | 64 | 1,204 | 366 |\n| CHAOS-MRI [25] | MR | 60 | 1,917 | 1,492 |\n| MSD-Liver [2] | CT | 131 | 58,638 | 19,163 |\n| AMOS22CT [23] | CT | 300 | 41,430 | 30,279 |\n| **Total** | **CT & MR** | **15,499** | **1,156,529** | **186,525** |", "caption": "Table 1: \nDataset Statistics of MedGen-1M.", "description": "This table presents a summary of the MedGen-1M dataset, a large-scale radiology image-text dataset used in the paper. It details the number of volumes, slices, and masks for both CT and MR images across several different datasets.  The inclusion of mask counts highlights the availability of annotations for training controlled data generation.", "section": "3. Data Curation"}, {"content": "| Source Dataset | Source Modality | Target Dataset | Target Modality | Source Domain | DualNorm [57] | CycleGAN [58] | MRGen (Ours) |\n|---|---|---|---|---|---|---|---| \n| CM. | T1 | CM. | T2-SPIR | 156.98 | 228.16 | 157.77 | **44.82** |\n| CM. | T2-SPIR | CM. | T1 | 156.98 | 261.97 | 188.91 | **60.79** |\n| MP. | T2 | MP. | ADC | 305.56 | 422.73 | 112.82 | **99.38** |\n| MP. | ADC | MP. | T2 | 305.56 | 416.31 | 190.82 | **123.55** |\n| PS. | T1 | PS. | T2 | 76.95 | 120.36 | 237.52 | **34.35** |\n| PS. | T2 | PS. | T1 | 76.95 | 126.27 | 89.26 | **58.90** |\n| LQ. | T1 | CM. | T2-SPIR | 109.46 | 281.56 | 182.62 | **88.76** |\n| CM. | T2-SPIR | LQ. | T1 | 109.46 | 246.73 | 260.06 | **106.45** |\n| MP. | ADC | PR. | T2 | 387.29 | 434.54 | 221.27 | **116.35** |\n| PR. | T2 | MP. | ADC | 387.29 | 365.10 | 140.72 | **88.43** |\n| AM. | CT | CM. | T1 | 148.04 | 226.23 | 248.06 | **42.53** |\n| AM. | CT | CM. | T2-SPIR | 164.73 | 259.96 | 268.49 | **65.30** |\n| ML. | CT | CM. | T2-SPIR | 176.51 | 265.64 | 307.79 | **96.72** |\n| **Average FID \u2193** |  |  |  | 197.06 | 281.20 | 200.47 | **78.95** |", "caption": "Table 2: \nQuantitative Results\u00a0(FID) on Generation.\nSmaller values indicate better performance.\nHere, CM., MP., PS., LQ., PR., AM., and ML., denote CHAOS-MRI, MSD-Prostate, PanSeg, LiQA, PROMISE12, AMOS22, and MSD-Liver, respectively.", "description": "This table presents a quantitative comparison of the image generation quality using different methods.  The metric used is the Fr\u00e9chet Inception Distance (FID), where lower scores indicate better performance. The table compares the FID scores achieved by three methods: MRGen (the proposed method), CycleGAN, and DualNorm.  The evaluation is performed across multiple cross-modal scenarios, using different source and target MRI modalities. Acronyms for datasets (CHAOS-MRI, MSD-Prostate, PanSeg, LiQA, PROMISE12, AMOS22, and MSD-Liver) are defined for better readability.", "section": "5. Experiments"}, {"content": "| Source Dataset | Source Modality | Target Dataset | Target Modality | DualNorm [57] | nnUNet [21] | UMamba [34] |\n|---|---|---|---|---|---|---|\n| \ud835\udcacs | CycleGAN | MRGen | \ud835\udcacs | CycleGAN | MRGen | Oracle Box | SAM2 | nnUNet [21] | \ud835\udcact |\n|---|---|---|---|---|---|---|---|---|---|---|\n| *Same Datasets, Different Modalities* |\n| CHAOS-MRI | T1 | CHAOS-MRI | T2-SPIR | 14.00 | 6.90 | 7.58 | 66.18 | 4.02 | 10.58 | **67.35** | 45.45 | 53.12 | 83.90 |\n| CHAOS-MRI | T2-SPIR | CHAOS-MRI | T1 | 12.50 | 0.80 | 1.38 | **58.10** | 0.62 | 0.22 | **57.24** | 43.48 | 51.94 | 90.60 |\n| MSD-Prostate | T2 | MSD-Prostate | ADC | 1.43 | 5.52 | 40.92 | **57.83** | 0.19 | 45.06 | **52.58** | 61.50 | 65.39 | 82.35 |\n| MSD-Prostate | ADC | MSD-Prostate | T2 | 12.94 | 22.20 | 57.06 | 61.95 | 11.80 | **62.00** | **64.05** | 61.07 | 66.40 | 89.80 |\n| PanSeg | T1 | PanSeg | T2 | 0.21 | 0.68 | 2.40 | **9.78** | 0.38 | 2.13 | **9.34** | 31.69 | 41.11 | 82.28 |\n| PanSeg | T2 | PanSeg | T1 | 0.11 | 0.30 | 3.59 | **12.07** | 0.27 | 5.08 | **10.29** | 30.94 | 41.18 | 80.27 |\n| *Different Datasets, Different Modalities* |\n| LiQA | T1 | CHAOS-MRI | T2-SPIR | 19.23 | 16.20 | 7.84 | **31.73** | 11.05 | 8.65 | **37.30** | 62.72 | 70.86 | 70.83 |\n| CHAOS-MRI | T2-SPIR | LiQA | T1 | 31.09 | 15.80 | 41.02 | **57.28** | 10.33 | 41.22 | **52.54** | 56.11 | 67.99 | 93.60 |\n| MSD-Prostate | ADC | PROMISE12 | T2 | 1.43 | 17.19 | **42.13** | 35.33 | 23.71 | **43.24** | 37.12 | 50.41 | 53.61 | 87.00 |\n| PROMISE12 | T2 | MSD-Prostate | ADC | 9.84 | 19.20 | **59.95** | 56.88 | 21.75 | **57.21** | 49.77 | 61.50 | 65.39 | 82.35 |\n| *Different Datasets, Different Modalities, CT - MRI* |\n| AMOS22 | CT | CHAOS-MRI | T1 | 19.78 | 0.11 | 6.75 | **22.50** | 0.05 | 8.06 | **26.73** | 43.48 | 51.94 | 90.60 |\n| AMOS22 | CT | CHAOS-MRI | T2-SPIR | 16.09 | 8.88 | 52.49 | **56.23** | 3.19 | 43.21 | **60.53** | 45.45 | 53.12 | 83.90 |\n| MSD-Liver | CT | CHAOS-MRI | T2-SPIR | 1.58 | 3.12 | 10.14 | **38.67** | 1.65 | 11.06 | **40.93** | 62.72 | 70.86 | 70.83 |\n| *Average DSC score* | 10.79 | 8.99 | 25.63 | **43.43** | 6.85 | 25.89 | **43.52** | 50.50 | 57.92 | 83.72 |", "caption": "Table 3: \nQuantitative Results\u00a0(DSC score) on Segmentation.\nOracle Box denotes the DSC score compared between the perturbed oracle box prompts for SAM2, and the ground truth;\n\ud835\udc9fssubscript\ud835\udc9f\ud835\udc60\\mathcal{D}_{s}caligraphic_D start_POSTSUBSCRIPT italic_s end_POSTSUBSCRIPT and \ud835\udc9ftsubscript\ud835\udc9f\ud835\udc61\\mathcal{D}_{t}caligraphic_D start_POSTSUBSCRIPT italic_t end_POSTSUBSCRIPT denote training with real and manually annotated source-domain and target-domain data respectively.\nResults are organized by three different cross-modality simulations, where the best results under nnUNet and UMamba are bolded respectively, while the second best are underlined.", "description": "This table presents the quantitative segmentation results using the Dice Similarity Coefficient (DSC) metric.  It compares the performance of different methods: nnUNet and UMamba trained on various data sources. The data sources include: real manually annotated source-domain data (Ds), source-domain data augmented using DualNorm, source-domain data translated to the target domain using CycleGAN, target-domain data generated by the proposed MRGen model, and finally, real manually annotated target-domain data (Dt) acting as an oracle. The table is organized into three sections representing different cross-modality scenarios, highlighting the best and second-best performing models (nnUNet and UMamba) for each scenario. The \"Oracle Box\" column shows the DSC score of using SAM2 with perturbed oracle box prompts as input.", "section": "5. Experiments"}, {"content": "| Method | AutoFilter | \\mathcal{D}_{t} Image | CHAOS-MRI [25] | MSD-Prostate [2] |\n|---|---|---|---|---|\n| T1 \\rightarrow T2S | T2S \\rightarrow T1 | T2 \\rightarrow ADC | ADC \\rightarrow T2 |\n| nnUNet [21] | \u2717 | \u2717 | 6.90 | 0.80 |\n| nnUNet (**MRGen**) | \u2717 | \u2717 | 16.53 | 15.10 |\n|  | \u2713 | \u2717 | 22.30 | 20.27 |\n|  | \u2717 | \u2713 | 30.16 | 29.01 |\n|  | \u2713 | \u2713 | **66.18** | **58.10** |", "caption": "Table 4: \nAblation Study on Segmentation Performance\u00a0(DSC score).\nHere, T2S. denotes T2-SPIR.", "description": "This ablation study analyzes the impact of different components of the MRGen model on the Dice Similarity Coefficient (DSC) scores achieved in MRI segmentation tasks.  Specifically, it compares the performance of nnUNet models trained using synthetic data generated by MRGen with various configurations.  The configurations include variations in whether or not an automatic filter is used and whether training incorporates both source domain data (with mask annotations) and target domain data (without mask annotations).  The results illustrate how these design choices affect the ability of the model to generalize to unseen modalities.", "section": "5.4. Ablation Studies"}, {"content": "| Dataset | Organs | Modality | Train # Vol. | Train # Slc. | Train # Slc. w/ mask | Test # Vol. | Test # Slc. | Test # Slc. w/ mask |\n|---|---|---|---|---|---|---|---|---|\n| LiQA [31] | Liver | T1-weighted | 24 | 1,718 | 1,148 | 6 | 467 | 298 |\n| PanSeg [54] | Pancreas | T1-weighted | 309 | 14,656 | 5,961 | 75 | 3,428 | 1,400 |\n|  |  | T2-weighted | 305 | 12,294 | 5,106 | 77 | 2,982 | 1,312 |\n| MSD-Prostate [2] | Prostate | T2-weighted | 26 | 492 | 100 | 6 | 110 | 83 |\n|  |  | ADC | 26 | 492 | 100 | 6 | 110 | 83 |\n| PROMISE12 [29] | Prostate | T2-weighed | 40 | 1,137 | 645 | 10 | 110 | 133 |\n| CHAOS-MRI [25] | Liver, Right Kidney,  | T1-weighted | 32 | 1,018 | 770 | 8 | 276 | 230 |\n|  | Left Kidney, Spleen | T2-SPIR | 16 | 503 | 388 | 4 | 120 | 104 |\n| MSD-Liver [2] | Liver | CT | 105 | 46,695 | 15,260 | 26 | 11943 | 3903 |\n| AMOS22CT [23] | Liver, Right Kidney,  | CT | 200 | 26,069 | 19,023 | 100 | 15,361 | 11,256 |\n|  | Left Kidney, Spleen, *etc.* |  |  |  |  |  |  |  |\n| **Total** | / | / | **1,083** | **105,074** | **48,501** | **218** | **34,907** | **18,802** |", "caption": "Table 5: \nDetails of Segmentation-annotated Datasets in MedGen-1M.\nHere, #\u00a0Vol. represents the number of 3D Volumes, #\u00a0Slc. denotes the number of 2D slices, and #\u00a0Slc.\u00a0w/\u00a0mask indicates the number of 2D slices with mask annotations.\n*: AMOS22CT\u00a0[23] also contains images and mask annotations for the following organs: Gallbladder, Esophagus, Stomach, Aorta, Inferior Vena Cava, Pancreas, Duodenum, Urinary Bladder, and Adrenal Gland.", "description": "Table 5 presents details of the segmentation-annotated datasets included in MedGen-1M. It shows the number of 3D volumes, the number of 2D slices, and the number of 2D slices with mask annotations for each dataset.  Specifically, it lists the dataset name, the organs annotated, the modality of the images, and the counts for 3D volumes, 2D slices, and 2D slices with masks, both for the training and testing sets. An additional note clarifies that the AMOS22CT dataset contains annotations for additional organs beyond those listed in the main table.", "section": "3. Data Curation"}, {"content": "| Dataset | Source | Modality | Target | Modality | \\mathcal{D}_{s} | \\mathcal{D}_{t} |\n|---|---|---|---|---|---|---|\n|  |  |  |  |  | \\mathcal{D}_{s} | \\mathcal{D}_{t} |\n| CHAOS-MRI [25] | T1 | T2-SPIR | 90.60 | **88.14** | 4.02 | **67.35** |\n|  | T2-SPIR | T1 | 83.90 | **82.06** | 0.62 | **57.24** |", "caption": "Table 6: \nMore Quantitative Results\u00a0(DSC score) on Segmentation.\nWe compare the performance of nnUNet\u00a0[21] trained on real data versus synthetic data generated by our MRGen in both the source domain\u00a0(\ud835\udc9fssubscript\ud835\udc9f\ud835\udc60\\mathcal{D}_{s}caligraphic_D start_POSTSUBSCRIPT italic_s end_POSTSUBSCRIPT) and target domain\u00a0(\ud835\udc9ftsubscript\ud835\udc9f\ud835\udc61\\mathcal{D}_{t}caligraphic_D start_POSTSUBSCRIPT italic_t end_POSTSUBSCRIPT).", "description": "Table 6 presents a quantitative comparison of the segmentation performance achieved using the nnUNet model trained on real versus synthetic data.  The synthetic data was generated using the MRGen method.  The comparison is made for both the source domain (the domain from which the original data for training was obtained) and the target domain (the domain for which the synthetic data was generated for model evaluation).  The results are expressed as Dice Similarity Coefficient (DSC) scores, a common metric for evaluating segmentation accuracy.", "section": "5. Experiments"}]